Abiopharma

Decision of the US District Court for the Southern District of New York in the TriZetto re-trial

Décision du tribunal américain du district Sud de New York dans le cadre du nouveau procès TriZetto

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Immediate Report

Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour lamlitelimab dans la dermatite atopique lors dune session de dernière minute

Press Release: AAD: new results from Sanofis amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo